13F filer · CIK 1017645
GENERAL ATLANTIC, L.P.
New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$2.9B
+$758.6M vs prior
Positions
12
New / sold out
3 / 3
Added / reduced
1 / 3
Turnover
10.8%
buys $855.9M · sells $272.5M
Top-10 weight
99.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | LIFTOFF MOBILE | +25,315,646 | – | +$608.1M |
| New | SEAPORT THERAPEUTICS | +6,101,582 | – | +$132.5M |
| Added | ALKAMI | +4,041,543 | +26.4% | +$73.2M |
| New | PARABILIS MEDICINES | +1,538,461 | – | +$42.1M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | EUROPEAN WAX CENTER | -13,110,492 | -100.0% | $-75.8M |
| Reduced | REVOLUTION MEDICINES | -350,000 | -49.4% | $-65.5M |
| Sold out | CENTESSA PHARMACEUTICALS | -1,354,830 | -100.0% | $-53.8M |
| Reduced | PHARVARIS | -1,480,495 | -18.4% | $-51.2M |
| Reduced | NURIX THERAPEUTICS | -1,069,680 | -26.1% | $-26.0M |
| Sold out | WEBULL | -50,816 | -100.0% | $-243.9K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LIFTOFF MOBILECOM | 25,315,646 | $608.1M | 20.92% |
| 2 | DLOCALCL A | 46,656,695 | $606.3M | 20.86% |
| 3 | CHIMECOM SHS CL A | 21,259,683 | $435.4M | 14.98% |
| 4 | ALKAMICOM | 19,379,038 | $351.1M | 12.08% |
| 5 | XP, INCCL A | 20,566,133 | $334.4M | 11.50% |
| 6 | PHARVARISCOM | 6,550,757 | $226.5M | 7.79% |
| 7 | SEAPORT THERAPEUTICSCOM | 6,101,582 | $132.5M | 4.56% |
| 8 | NURIX THERAPEUTICSCOM | 3,032,185 | $73.6M | 2.53% |
| 9 | REVOLUTION MEDICINESCOM | 357,791 | $67.0M | 2.31% |
| 10 | PARABILIS MEDICINESCOM | 1,538,461 | $42.1M | 1.45% |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.